Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics”
Experts' disagreement on the interpretation of contraindications in SmPCs using clinical example cases indicates that further efforts are needed to improve their usability in clinical routine.
Authors
- Renke Maas (ORCID: https://orcid.org/0000-0002-5498-9761)
- Wahram Andrikyan (ORCID: https://orcid.org/0000-0002-4885-9864)
- Pauline Dürr (ORCID: https://orcid.org/0000-0001-5772-4956)
- Martin F. Fromm (ORCID: https://orcid.org/0000-0002-0334-7478)
- Katrin Farker (ORCID: https://orcid.org/0000-0001-5768-0754)
- Melanie Straubmeier
- Lea Jung‐Poppe (ORCID: https://orcid.org/0000-0002-3984-3131)
- Laura Weisbach (ORCID: https://orcid.org/0000-0003-0548-1870)
- Michael Hartmann (ORCID: https://orcid.org/0000-0002-6777-4540)
- Anna K. Schuster (ORCID: https://orcid.org/0000-0002-5958-4560)
- Michael I. Sponfeldner (ORCID: https://orcid.org/0009-0000-8236-0074)
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum Erlangen (DE)
- Jena University Hospital (DE)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1111/bcp.16331
- Primary Topic
- Pharmacy and Medical Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung